Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03582722 · ClinicalTrials.gov registry record · Phase 4
Weight Loss Aid in an Exposed Population
A Phase 4 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT03582722: Completed Phase 4 study, sponsored by Emory University.
NCT03582722 is a Phase 4 study that has completed, run by Emory University. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03582722, a Phase 4 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study will explore whether the use of orlistat results in weight loss that is accompanied by a reduction in the body burdens of polybrominated biphenyls (PBB) and other Persistent Organic Pollutants (POPs).
Primary Outcome
Participant weight, in kilograms, was measured in light clothing without shoes on a regularly calibrated digital scale.
Interventions
- DIETARY_SUPPLEMENT Multivitamin
- DRUG Orlistat
- DRUG Placebo capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2022-06-30 |
| Phase | Phase 4 |
What the finished NCT03582722 record still lists
NCT03582722 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 3 interventions - of which Multivitamin is the first listed.
NCT03582722 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03582722 about?
NCT03582722 is a clinical study titled "Weight Loss Aid in an Exposed Population". This study will explore whether the use of orlistat results in weight loss that is accompanied by a reduction in the body burdens of polybrominated biphenyls (PBB) and other Persistent Organic Pollutants (POPs).
What is the current status of trial NCT03582722?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2018-09-14. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT03582722?
The interventions under investigation include: Multivitamin (DIETARY_SUPPLEMENT), Orlistat (DRUG), Placebo capsule (DRUG).
Who is sponsoring clinical trial NCT03582722?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03582722's enrollment target sits among peer trials
100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI